MultiplAI combines next-generation RNA sequencing and artificial intelligence to develop an accessible, affordable and highly accurate blood test to screen for the world’s biggest killer LONDON, UK, Mar. 2, 2023 — MultiplAI Health, a techbio diagnostics company Read More